308 related articles for article (PubMed ID: 35663962)
21. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles.
Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK
Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003
[TBL] [Abstract][Full Text] [Related]
22. TREM2 Function in Alzheimer's Disease and Neurodegeneration.
Ulrich JD; Holtzman DM
ACS Chem Neurosci; 2016 Apr; 7(4):420-7. PubMed ID: 26854967
[TBL] [Abstract][Full Text] [Related]
23. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
24. TREM2 and the Progression of Alzheimer's Disease.
Gao L; Jiang T; Yao X; Yu L; Yang X; Li Y
Curr Neurovasc Res; 2017; 14(2):177-183. PubMed ID: 28393702
[TBL] [Abstract][Full Text] [Related]
25. Different mechanisms of apolipoprotein E isoform-dependent modulation of prostaglandin E2 production and triggering receptor expressed on myeloid cells 2 (TREM2) expression after innate immune activation of microglia.
Li X; Montine KS; Keene CD; Montine TJ
FASEB J; 2015 May; 29(5):1754-62. PubMed ID: 25593125
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.
Schmitz TW; Soreq H; Poirier J; Spreng RN
J Neurosci; 2020 Feb; 40(9):1931-1942. PubMed ID: 31915256
[TBL] [Abstract][Full Text] [Related]
27. TREM2 ectodomain and its soluble form in Alzheimer's disease.
Yang J; Fu Z; Zhang X; Xiong M; Meng L; Zhang Z
J Neuroinflammation; 2020 Jul; 17(1):204. PubMed ID: 32635934
[TBL] [Abstract][Full Text] [Related]
28. Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease.
Jay TR; Hirsch AM; Broihier ML; Miller CM; Neilson LE; Ransohoff RM; Lamb BT; Landreth GE
J Neurosci; 2017 Jan; 37(3):637-647. PubMed ID: 28100745
[TBL] [Abstract][Full Text] [Related]
29. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
[TBL] [Abstract][Full Text] [Related]
30. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
Parhizkar S; Arzberger T; Brendel M; Kleinberger G; Deussing M; Focke C; Nuscher B; Xiong M; Ghasemigharagoz A; Katzmarski N; Krasemann S; Lichtenthaler SF; Müller SA; Colombo A; Monasor LS; Tahirovic S; Herms J; Willem M; Pettkus N; Butovsky O; Bartenstein P; Edbauer D; Rominger A; Ertürk A; Grathwohl SA; Neher JJ; Holtzman DM; Meyer-Luehmann M; Haass C
Nat Neurosci; 2019 Feb; 22(2):191-204. PubMed ID: 30617257
[TBL] [Abstract][Full Text] [Related]
31. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
32. Loss of TREM2 Confers Resilience to Synaptic and Cognitive Impairment in Aged Mice.
Qu W; Li L
J Neurosci; 2020 Dec; 40(50):9552-9563. PubMed ID: 33139402
[TBL] [Abstract][Full Text] [Related]
33. Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer's disease.
Toomey CE; Heywood W; Benson BC; Packham G; Mills K; Lashley T
Brain Pathol; 2020 Jul; 30(4):794-810. PubMed ID: 32267026
[TBL] [Abstract][Full Text] [Related]
34. Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
Raha-Chowdhury R; Henderson JW; Raha AA; Stott SRW; Vuono R; Foscarin S; Wilson L; Annus T; Fincham R; Allinson K; Devalia V; Friedland RP; Holland A; Zaman SH
J Alzheimers Dis; 2018; 61(3):1143-1162. PubMed ID: 29278889
[TBL] [Abstract][Full Text] [Related]
35. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease.
Claes C; Danhash EP; Hasselmann J; Chadarevian JP; Shabestari SK; England WE; Lim TE; Hidalgo JLS; Spitale RC; Davtyan H; Blurton-Jones M
Mol Neurodegener; 2021 Jul; 16(1):50. PubMed ID: 34301296
[TBL] [Abstract][Full Text] [Related]
36. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
[TBL] [Abstract][Full Text] [Related]
37. The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E.
Bailey CC; DeVaux LB; Farzan M
J Biol Chem; 2015 Oct; 290(43):26033-42. PubMed ID: 26374897
[TBL] [Abstract][Full Text] [Related]
38. CD200-, CX3CL1-, and TREM2-mediated neuron-microglia interactions and their involvements in Alzheimer's disease.
Zhang L; Xu J; Gao J; Wu Y; Yin M; Zhao W
Rev Neurosci; 2018 Nov; 29(8):837-848. PubMed ID: 29729150
[TBL] [Abstract][Full Text] [Related]
39. New insights into the role of TREM2 in Alzheimer's disease.
Gratuze M; Leyns CEG; Holtzman DM
Mol Neurodegener; 2018 Dec; 13(1):66. PubMed ID: 30572908
[TBL] [Abstract][Full Text] [Related]
40. Imbalance of Microglial TLR4/TREM2 in LPS-Treated APP/PS1 Transgenic Mice: A Potential Link Between Alzheimer's Disease and Systemic Inflammation.
Zhou J; Yu W; Zhang M; Tian X; Li Y; Lü Y
Neurochem Res; 2019 May; 44(5):1138-1151. PubMed ID: 30756214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
